PDE1C
Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C
Also known as: Hcam3, PDE1C_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14123
- Gene
- PDE1C
- Ensembl
- ENSG00000154678
- Chromosome
- 7
- Canonical length
- 709 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes an enzyme that belongs to the 3'5'-cyclic nucleotide phosphodiesterase family. Members of this family catalyze hydrolysis of the cyclic nucleotides, cyclic adenosine monophosphate and cyclic guanosine monophosphate, to the corresponding nucleoside 5'-monophosphates. The enzyme encoded by this gene regulates proliferation and migration of vascular smooth muscle cells, and neointimal hyperplasia. This enzyme also plays a role in pathological vascular remodeling by regulating the stability of growth factor receptors, such as PDGF-receptor-beta. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
709 residues, UniProt reviewed canonical sequence.
>Q14123|PDE1C
1 MESPTKEIEE FESNSLKYLQ PEQIEKIWLR LRGLRKYKKT SQRLRSLVKQ LERGEASVVD
61 LKKNLEYAAT VLESVYIDET RRLLDTEDEL SDIQSDAVPS EVRDWLASTF TRQMGMMLRR
121 SDEKPRFKSI VHAVQAGIFV ERMYRRTSNM VGLSYPPAVI EALKDVDKWS FDVFSLNEAS
181 GDHALKFIFY ELLTRYDLIS RFKIPISALV SFVEALEVGY SKHKNPYHNL MHAADVTQTV
241 HYLLYKTGVA NWLTELEIFA IIFSAAIHDY EHTGTTNNFH IQTRSDPAIL YNDRSVLENH
301 HLSAAYRLLQ DDEEMNILIN LSKDDWREFR TLVIEMVMAT DMSCHFQQIK AMKTALQQPE
361 AIEKPKALSL MLHTADISHP AKAWDLHHRW TMSLLEEFFR QGDREAELGL PFSPLCDRKS
421 TMVAQSQVGF IDFIVEPTFT VLTDMTEKIV SPLIDETSQT GGTGQRRSSL NSISSSDAKR
481 SGVKTSGSEG SAPINNSVIS VDYKSFKATW TEVVHINRER WRAKVPKEEK AKKEAEEKAR
541 LAAEEQQKEM EAKSQAEEGA SGKAEKKTSG ETKNQVNGTR ANKSDNPRGK NSKAEKSSGE
601 QQQNGDFKDG KNKTDKKDHS NIGNDSKKTD GTKQRSHGSP APSTSSTCRL TLPVIKPPLR
661 HFKRPAYASS SYAPSVSKKT DEHPARYKML DQRIKMKKIQ NISHNWNRKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDE1C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 55 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 55 nTPM
- spinal cord: 22 nTPM
- hippocampal formation: 17 nTPM
- midbrain: 17 nTPM
- fallopian tube: 16 nTPM
- basal ganglia: 15 nTPM
Single-cell type
- salivary ionocytes: 2,229 nCPM
- respiratory ionocytes: 1,852 nCPM
- cardiomyocytes: 1,734 nCPM
- renal collecting duct intercalated cells: 1,636 nCPM
- oligodendrocytes: 1,240 nCPM
- retinal bipolar cells: 687 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 153 nTPM
- cerebral cortex: 106 nTPM
- basal ganglia: 102 nTPM
- medulla oblongata: 76 nTPM
- thalamus: 74 nTPM
- midbrain: 72 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PDE1C.
Disease | AllUniProt
Conditions PDE1C is implicated in, by any mechanism.
- Deafness, autosomal dominant, 74 (DFNA74) MIM:618140
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 184 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hearing loss, autosomal dominant 74
- Autosomal dominant nonsyndromic hearing loss
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.39
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- 3',5'-cyclic-AMP phosphodiesterase activity
- 3',5'-cyclic-GMP phosphodiesterase activity
- calmodulin binding
- calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity
- calmodulin-activated dual specificity 3',5'-cyclic-GMP, 3',5'-cyclic-AMP phosphodiesterase activity
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain
- HD/PDEase domain
- PDE1, N-terminal domain
- 3'5'-cyclic nucleotide phosphodiesterase
- 3'5'-cyclic nucleotide phosphodiesterase, conserved site
- 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain superfamily
- 3'5'-cyclic nucleotide phosphodiesterase
- 3'5'-cyclic nucleotide phosphodiesterase N-terminal
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDE1C as an antibody target. Whether an autoantibody or antibody against PDE1C could matter depends on whether native PDE1C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDE1C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PDE1C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...